In sickle cell disease (SCD), sickle hemoglobin (HbS) polymerizes upon deoxygenation, resulting in sickling of red blood cells (RBCs). These sickled RBCs have strongly reduced deformability, leading to vaso-occlusive crises and chronic hemolytic anemia. To date, there are no reliable laboratory parameters or assays capable of predicting disease severity or monitoring treatment effects. We here report on the oxygenscan, a newly developed method to measure RBC deformability (expressed as Elongation Index -EI) as a function of pO 2 . Upon a standardized, 22 minute, automated cycle of deoxygenation (pO 2 median 16 mmHg ± 0.17) and reoxygenation, a number of clinically relevant parameters are produced in a highly reproducible manner (coefficients of variation <5%). In particular, physiological modulators of oxygen affinity, such as, pH and 2,3-diphosphoglycerate showed a significant correlation (respectively R = -0.993 and R = 0.980) with Point of Sickling (PoS 5% ), which is defined as the pO 2 where a 5% decrease in EI is observed during deoxygenation. Furthermore, in vitro treatment with antisickling agents, including GBT440, which alter the oxygen affinity of hemoglobin, caused a reproducible left-shift of the PoS, indicating improved deformability at lower oxygen tensions. When RBCs from 21 SCD patients were analyzed, we observed a significantly higher PoS in untreated homozygous SCD patients compared to treated patients and other genotypes. We conclude that the oxygenscan is a state-of-the-art technique that allows for rapid analysis of sickling behavior in SCD patients. The method is promising for personalized treatment, development of new treatment strategies and could have potential in prediction of complications.
| INTRODUCTION
In sickle cell disease (SCD) a single point mutation in the gene encoding for β-globin chain underlies the production of the abnormal hemoglobin S (HbS). HbS polymerizes upon deoxygenation which results in the formation of hemoglobin polymers and eventually gives the red blood cell (RBC) its characteristic sickled shape. Exacerbating the hypoxiainduced polymerization is the inherent low-affinity of HbS, presumably due to high levels of 2,3-diphosphoglycerate (2,3-DPG) present in sickle RBCs. 1 These sickled RBCs have strongly reduced deformability and show increased adherence to vascular endothelium, leading to vasoocclusive crises. [2] [3] [4] Hydroxyurea (HU), regular blood transfusion, and L-glutamine are the main treatment options in SCD, with allogeneic hematopoietic stem cell transplantation being the only curative therapy currently available. 5 Remarkably, clinical severity varies considerably despite the fact that all SCD patients carry the same homozygous point mutation in the β-globin gene. To date there is no reliable laboratory or clinical parameter available to predict severity and/or complications.
An individual patient's tendency to "sickle" can be tested in vitro using a so-called sickling assay: RBCs are incubated under hypoxic conditions and manually or digitally counted using a light microscope.
This assay is still widely applied in research, and many preclinical and early phase pharmacologic and gene therapy trials use this assay as outcome variable to predict clinical effect. [6] [7] [8] [9] [10] [11] However, there are many disadvantages: It is time consuming, it has low sensitivity and high variability, and the process is not automated. More importantly, morphological characteristics of sickle cells may not correlate well with physiologic characteristics, such as deformability. 12 RBC deformability at normoxic conditions is compromised in patients with SCD due to irreversibly sickled cells, as well as altered hydration causing a decrease in surface/volume ratio. [12] [13] [14] Osmotic gradient ektacytometry, in which deformability is measured as a function of a continuous change in osmolarity, is a well-established method, in particular in hereditary disorders of the red cell membrane. [15] [16] [17] [18] In SCD, osmotic gradient ektacytometry showed that increasing HbF induces a better surface-to-volume ratio thereby improving deformability in untransfused patients with SCD. 19 RBC deformability during normoxic conditions as a marker for complications has also been investigated in the past, and a negative correlation was found between an increase in RBC deformability and osteonecrosis or painful sickle cell crises. [20] [21] [22] In contrast to these findings, RBC deformability was found to be decreased during an acute vaso-occlusive crises when compared to steady state values. 23 Thus, in itself, RBC deformability during normoxic conditions gives inconsistent results which makes it unsuitable to be used as predictive biomarker.
Therefore, an assay that investigates sickling during deoxygenation is required to monitor treatment and disease state in patients with SCD.
Importantly, this assay could identify individuals who are at increased risk for certain complications, and potentially predict response to therapy. Figure 1A ). Light from the laser beam is scattered by the presence of RBCs and this diffraction pattern is projected and analyzed. In healthy controls, the diffraction pattern is circular at rest and elliptical shaped at higher shear stress ( Figure 1B ).
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To carry out the oxygenscan, 50μL of whole blood, standardized to a fixed RBC count of 200 × 10 6 is suspended into 5 mL Iso Oxy (osmolarity 282-286 mOsm/kg, pH 7.35-7.45) at room temperature (± 22°C).
Approximately 2 mL of the sample solution is slowly injected into the gap between the cup and bob until a fixed level is attained ( Figure 1C ). The bob is maintained at a constant temperature of 37°C. Inlet of nitrogen gas from above facilitates deoxygenation ( Figure 1C 
| Oxygenscan parameters
When considering a typical oxygenscan curve ( Figure 1F ), 6 parameters are considered to reflect various features of the process of HbS polymerization or sickling: EImax: maximum EI before deoxygenation that represents baseline position and shows overall deformability of the total RBC population. EImin: minimum EI, representing minimal deformability resulting from changes in shape and orientation of (sickle) RBCs upon deoxygenation ( Figure 1D 
| In vitro addition of HbAA blood to HbSS blood, mimicking red cell transfusions
To investigate the effect of adding RBCs of healthy donors, ABO and rhesus matched RBCs of a healthy donor was mixed with whole blood of a patient with SCD to reach the following percentages of HbS blood: 100%, 75%, 50%, 25%, and 0%.
| Influence of 2,3-DPG levels, pH, and temperature
To assess the influence of 2,3-DPG levels on oxygenscan parameters, complete blood count and oxygenscans were performed within 10 minutes after blood collection, and after 24 hours. Whole blood was kept either at 4°C, room temperature (± 22°C) and 37°C for 24 hours.
2,3-DPG was measured by spectrophotometry (SpectraMax M2e, Molecular Devices, Sunnyvale, CA) using the 2,3-DPG assay kit (Roche).
2,3-DPG levels were normalized to hemoglobin levels.
To assess the influence of temperature, oxygenscans were carried out with bob temperatures of 35, 37, 39, 41, and 43°C.
To investigate the influence of pH, the pH of the Iso Oxy was set to 6.9, 7.1, 7.3, 7.7, and 7.9 before being used in the oxygenscan.
| In vitro incubation with antisickling agents GBT440, 5-PMFC, and INN312
GBT440 , Antisickling agents were dissolved in dimethyl sulfoxide (DMSO), while incubation with DMSO alone was used as a negative control.
| Morphological analysis after in vitro incubation with antisickling agents
To compare the outcome of the effect of the agents mentioned earlier, sickling was also measured using previously reported methodology with slight modifications. 7, 10, 27 Briefly, whole blood was suspended (20% hematocrit) in isotonic Hemox buffer (TCS Scientific Corp), pH 7.4, supplemented with 10 mM glucose and 0.2% bovine serum albumin and incubated at normoxia in varying concentrations of GBT440 (1, 2 and 5 mM), 5-PMFC (1 and 5 mM), and INN312 (1 and 5 mM) at 37°C for 1 hour. Next, suspensions were incubated under hypoxic condition (2.5% Oxygen gas/97.5% Nitrogen gas) at 37°C for 1 hour. Cells were fixed and analyzed by light microscopy.
| Statistical analysis
Experiments were mainly carried out in duplicates, mean, SD, and coeffi- A representative oxygenscan and its derived parameters is shown in Figure 1F . Importantly, parameters from duplicate measurements generally had a CV <5% (median 1.83%). In case a CV >5% was obtained, a third measurement was performed. The parameters EImax and Recovery appeared to be the most robust with median CVs <1%.
Measurements of pO 2 and EI are not performed at the same position in the cup. This ensures a better discrimination between the deoxygenation and reoxygenation curves and, hence, a better interpretation of them.
In order to confirm that the change in diffraction pattern during deoxygenation reflects sickling, cells were deoxygenated outside the Lorrca, under comparable conditions, fixed and analyzed by light microscopy as described. Compared to oxygenated conditions sickling is clearly induced upon deoxygenation ( Figure 1E and Supporting Information).
Upon storage of whole blood at 4°C oxygenscan curves shifted slightly upward. When stored for 24 hours at 4°C curves remained stable, with minor increases in EImax (1.7%), PoS (2,7%), DeltaEI (9.2%), and Area (6.7%). Minor decreases of 6.7% in EImin and 0.6% in Recovery were observed under these conditions. Upon longer storage, oxygenscans shifted upward. (Supporting Information Table S1 ).
| The oxygenscan can adequately assess the effect of blood transfusion
In order to investigate the direct effects of blood transfusions on sickling behavior, RBCs of a healthy control (HC) was mixed with whole blood of a SCD patient in different amounts (Supporting Information Figure S2A ).
Supporting Information Figure S2B and S2G shows that EImax and EImin shifted toward normal upon increasing percentages of HbAA blood. At the same time the PoS shifted to the left (Supporting Information Figure S2D ), whereas DeltaEI decreased and Area increased (Supporting Information Figure S2C and S2E). Recovery also increased to 100%
(Supporting Information Figure S2F ).
All oxygenscan parameters correlated significantly with the percentage of whole blood. EImin showed a striking linear correlate of r = 0.998, Figure S2D and S2I).
Upon lowering the pH of Iso Oxy, an increase of EImax, DeltaEI, and PoS was observed, and EImin, Area, and Recovery decreased (Supporting Information Figure S3A -G). Upon increasing the pH, the opposite effect was observed (Supporting Information Figure S3A -G).
PoS appeared to correlate best with pH change (r = −0.993, P < 0.001 (pooled data, Supporting Information Figure S3K ), indicating that lowering pH results in sickling that starts at higher pO 2 .
Next, we performed series of oxygenscans of a single sample at different cup and bob temperatures. Results were similar as those found with pH adjustments (Supporting Information Figure S4 ). EImax decreased upon increased temperature and correlated best (linear correlate r = 0.996, P < 0.001), indicating RBC deformability at normoxic conditions is temperature dependent (Supporting Information Figure S4G ).
| The oxygenscan provides a means to evaluate the efficacy of antisickling agents
Currently several new drugs for SCD are being tested in clinical trials. With blood of 6 SCD patients we investigated 3 of those drugs (GBT440, 5-PMFC, and INN312) for their efficacy on directly preventing hypoxiainduced sickling using the oxygenscan as readout. GBT440 showed a large improvement in oxygenscan parameters at a concentration of 1 mM and an even larger effect at 2 mM (Figure 2A ). After incubation with GBT440, EImax slightly decreased. In contrast, EImin increased with increasing doses of GBT440, which was significant for 2 and 5 mM (P = 0.005 and 0.001, Figure 2B ). Similar to these findings, DeltaEI and PoS significantly improved with increasing GBT440 concentration (P < 0.001, Figure 2C Importantly, when oxygenscan parameters were compared with the conventional sickling assay (microscopy), the results showed similar patterns and were correlated (r = 0.934 P = 0.002, Figure 2F and G). However at a lower concentration of GBT440, and to lesser extent also 5-PMFC and INN312, a slightly larger antisickling effect was observed with the conventional sickling assay ( Figure 2F ).
| The oxygenscan is able to discriminate between different genotypes and treatment regimens
In order to investigate if the oxygenscan can detect differences between genotypes and treatment regimens, oxygenscans were per- and r = −0.852, both P < 0.001, Figure 4A -B and Supporting Information Figure S5 ). Digital microscopy findings of these patients were also correlated with oxygenscan parameters. EImax showed the strongest correlation with sickled cells at normoxia (r = 0.596, P = 0.019, Figure 4C ). (F) Normalized sickling after incubation in absence or presence of antisickling agents, measured by microscopy, after deoxygenation at 18 mmHg (2.5% O2). G, Linear correlation between Oxygenscan measured sickling by DeltaEI and microscopy. Error bar represents SD. ****P < 0.0001, ***P < 0.001, ** P < 0.01, *P < 0.05., ns, not significant. Dashed lines represent 95% confidence intervals
| DISCUSSION
The oxygenscan is a rapid and reproducible technique, that is developed to assess RBC sickling under automated continuous deoxygenation and reoxygenation. We report for the first time on the potential of the oxygenscan to monitor clinical conditions and parameters that influence HbS polymerization. We found strikingly strong correlations of oxygenscan parameters with physiological and pharmacological modulators of HbS polymerization that are much stronger than in previously reported assays. 11 Importantly, diverse physiologic and pharmacologic conditions correlated best with particular oxygenscan parameters. This underlines the specificity of the various oxygenscan parameters: Conditions mimicking exchange blood transfusion were found to specifically affect EImin, similarly to HbF and HbS levels ( Figure 4A-B) . Physiological modulators processes of unsickling. 28 We speculate that this reduced capacity to recover could be involved in the distinct vaso-occlusive phenotype of HbSC patients.
| EImin is a reliable biomarker of the efficacy of blood transfusion
Our results show a strong correlation of EImin with the distribution of EImin therefore is a potent parameter for assessing the direct effects of blood transfusion and distribution of HbS, HbF, and HbA.
We suggest EImin is mostly predicted by the percentage of cells that are not able to sickle at all and therefore is most influenced by blood transfusion and F-cells.
| The potency of antisickling agents is captured by DeltaEI
DeltaEI can be used as outcome parameter in the assessment of the efficacy of new treatments that inhibit sickling. As shown by the experiments mimicking blood transfusion (Supporting Information Figure S1 ), DeltaEI reflects the percentage of RBCs that sickle upon deoxygenation and as such is comparable with the conventional sickling assays (microscopy). In our experiments with the antisickling agents GBT440, 5-PMFC, and INN312, data of the conventional assay were compared to DeltaEI and a similar pattern was observed ( Figure 2E-F) . Overall, the effects were more pronounced in the conventional assay, which could be due to a longer exposure to hypoxic conditions in the latter. This results in a higher amount of sickled cells at the start, and thus a more pronounced 
| PoS discriminates between genotypes and different treatment regimens
We show that PoS correlates with 2,3-DPG levels and other modulators that have an effect on the hemoglobin dissociation curve, such as pH and temperature (Supporting Information Figure S2A , B, F, and J).
PoS is unique in its ability to determine the pO 2 at which RBCs start to sickle, and is therefore of high value in the development and clinical testing of new drugs, in particular antisickling agents. When considering individuals with HbS trait, PoS has a distinct value in this group compared to controls and SCD patients ( Figure 3G ). PoS also is the most informative parameter when considering different treatment in groups of SCD patients.
Based on these observations we conclude that PoS likely reflects properties of an individual's hemoglobin dissociation curve.
| EImax reflects percentage of sickled cells at normoxia and RBC hydration
In whole blood, the percentage of sickled cells at normoxia compared to relatively healthy cells seems to have the most pronounced effect on EImax. The number of sickled cells at normoxia correlated to EImax ( Figure 4C ), indicating that already sickled cells lower the overall deformability and thereby EImax. We suggest that EImax reflects the percentage of nondeformable cells at ambient air, which are the dense cells containing HbS polymer and sickled cells at normoxia.
| Comparison with other hypoxic deformability assays
In the past several approaches to measure RBC deformability under hypoxic conditions have been developed. All but one were based on a deoxygenation step that took place outside the ektacytometer. [32] [33] [34] [35] In contrast to the oxygenscan, these approaches involved either a deoxygenation or reoxygenation step, or used hypoxia and normoxia as different conditions. A very recent study demonstrated a strong effect of GBT440 on RBC deformability, but no pO 2 could be determined and related to the measurements. 36 The oxygenscan allows now for the first time the study of sickling behavior during both automated deoxygenation and reoxygenation in a reproducible and fast manner.
One of the strengths of the oxygenscan is that deformability is measured at a whole range of different oxygen tensions. Furthermore, the technique has an excellent reproducibility, the time to perform an oxygenscan measurement is relatively short and it takes only a small amount of whole blood. More importantly, the oxygenscan is a functional assay that determines various aspects of the sickling process, each represented by different parameters.
A limitation of the technique is that measurements are performed on the total RBC population. Therefore, individual differences in cellular behavior or subpopulations of cells are not considered and, consequently, outcome parameters always reflect the mean behavior of all cells. Also, the minimal pO 2 during deoxygenation does not reach 0 mmHg. Although this pO 2 is not a physiologically relevant value, it would be of interest to measure in order to see how much the EI would further decrease.
Our data show that apart from the influence of HbF, HbS, and HbA, this assay also takes individual hemoglobin dissociation curves and percentage of sickled cells at normoxia into account. Therefore, the oxygenscan is an assay which simultaneously determines a number of clinically important factors involved in SCD pathophysiology. As such it may represent a better alternative for the conventional sickling assay and fill the clinical need for a reliable biomarker. Current studies are aimed at investigating the applicability of the oxygenscan in the determination of clinical severity and vaso-occlusive crisis, as well as a more comprehensive analysis of the effect of current and new treatment strategies.
